Schroder Investment Management Group
IMNM icon

Schroder Investment Management Group’s Immunome IMNM Stock Holding History

Schroder Investment Management Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-263,867
Closed -$1.84M – 1204
2025
Q1 		$1.84M Buy
+263,867
New +$2.53M ﹤0.01% 919

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Schroder Investment Management Group's IMNM Position: Q2 2025 in Review

Schroder Investment Management Group sold out of Immunome (IMNM) in Q2 2025, closing a stake of 263,867 shares — an estimated $1.84M sold.

Schroder Investment Management Group first reported a position in IMNM in Q1 2025 and held it in 1 quarter. The position peaked at $1.84M in Q1 2025. 142 funds tracked by Wall St. Rank hold IMNM as of Q2 2025.

  • Schroder Investment Management Group reported no remaining Immunome position as of Q2 2025 after selling out during the quarter.
  • Schroder Investment Management Group sold 263,867 Immunome shares in Q2 2025, an estimated $1.84M.
  • Schroder Investment Management Group first reported a position in Immunome in Q1 2025 and held it in 1 quarter.
  • Schroder Investment Management Group's Immunome position peaked at $1.84M in Q1 2025.
  • 142 funds tracked by Wall St. Rank held Immunome as of Q2 2025.

Based on Schroder Investment Management Group's 13F filing for Q2 2025, filed 13 Aug 2025.